Mar 06

A common fear among women is to be stricken with breast cancer. A drug that would reduce or eliminate that risk sounds very appealing. However, a product that sounds too good to be true may be just that. Exemestane (Aromasin) is a new drug that researchers hoped might provide a safe way to prevent breast cancer; however, a new study has reported that the medication is associated with a risk for significant bone loss.

A research team led by Angela M Cheung MD published their findings February 6 online in the British medical Journal The Lancet .

Exemestane is currently used to prevent breast cancer; however, a large study published last June reported that its could reduce the risk of being stricken with breast cancer in the first place by about 65%, compared to a placebo, in women at increased risk of the disease.

Full article…

Tags: Breast Cancer , Cancer

Jul 23

THURSDAY, July 21 (HealthDay News) — New research finds that the targeted cancer drug Tarceva nearly triples the amount of time lung cancer patients survive without a recurrence and has fewer side effects than standard chemotherapy.

The authors of a study appearing in the July 21 online issue of The Lancet Oncology recommend using Tarceva (erlotinib) as a first-line treatment for patients with advanced non-small-cell lung cancer who have the particular gene mutation this drug targets.

Other experts agreed.

“This is a very important study [because] it shows that we can identify patients with a specific genetic marker and direct specific treatment toward them,” said Dr.

Full article…

Tags: Cancer , Lung Cancer

Jul 03

FRIDAY, July 1 (HealthDay News) — Kentucky has one of the nation’s highest death rates for colorectal cancer, surpassed only by Mississippi and Alaska, according to the U.S. Centers for Disease Control and Prevention.

Not coincidentally, about a decade ago Kentucky also had the nation’s second-worst screening rate for colon cancer.

But the Colon Cancer Prevention Project, based in Louisville, started in 2004 with a mission of turning around those statistics, said Claire Albright, the project’s executive director.

A local gastroenterologist, Dr. Whitney Jones, founded the project after years of watching the incidence and death rates for colon cancer rise in his state, Albright said.

“He just got sick of so many people dying of a highly preventable disease,” she said.

Full article…

Tags: Cancer , Colorectal Cancer

Jun 26

WEDNESDAY, June 29 (HealthDay News) — Routinely screening longtime smokers and former heavy smokers for lung cancer using CT scans can cut the death rate by 20 percent compared to those screened by chest X-ray, according to a major U.S. government study.

The National Lung Screening Trial included more than 53,000 current and former heavy smokers aged 55 to 74 who were randomly chosen to undergo either a “low-dose helical CT” scan or a chest X-ray once a year for three years.

Those results, which showed that those who got the CT scans were 20 percent less likely to die than those who received X-rays alone, were initially published in the journal Radiology in November 2010.

The new study, published online July 29 in the New England Journal of Medicine , offers a fuller analysis of the data from the trial, which was funded by the U.S.

Full article…

Tags: Cancer , Ct Scans , Lung Cancer

Page 1 of 5 1 2 3 5